Join
Live feed
·
INSIDERFilingvia Quantisnow
Neoleukin Therapeutics Inc. logo

SEC Form 4: Patel Priti converted options into 35,000 shares and sold $8,588 worth of shares (14,380 units at $0.60), increasing direct ownership by 197% to 31,082 units to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NLTX (Neoleukin Therapeutics Inc.) and more on Quantisnow.